Licit use of illicit drugs for treating depression: the pill and the process.
The Journal of clinical investigation June 17, 2024 Alejandro Torrado Pacheco, Bita Moghaddam 3 citations
Psilocybin, MDMA, and ketamine have emerged as potentially effective treatments for rapid amelioration of the symptoms of mood and related psychiatric disorders. All clinical data collected so far with regard to psilocybin or MDMA, which have reported positive outcomes for treating depression, anxiety, posttraumatic stress disorder, and drug or alcohol use disorders, have involved...